312

Address: Geschäftsstelle
Röntgenweg 11
72076 Tübingen


frontend.sr-only_#{element.icon}: +49 (0)7071-29 83625


frontend.sr-only_#{element.icon}: ifitoffice@med.uni-tuebingen.de


iFIT associated Professorships

Prof. Dr. Judith Feucht

© Universitätsklinikum Tübingen / Beate Armbruster
Professorship for Cellular Immunotherapies in Cancer

Prof. Dr. Judith Feucht has taken up her W2 professorship for Cellular Immunotherapies in Cancer at the Faculty of Medicine on September 1, 2023. Prof. Feucht has dedicated her scientific career to CAR-T cell therapy, which has achieved remarkable clinical success in certain hematological diseases, leading to the approval of CAR therapy by the FDA and EMA. Despite the clinical success, treatment with currently approved CAR designs leads to a complete cure in only a fraction of patients. Her research group therefore aims to improve and expand cellular therapies by reprogramming immune cells through innovative gene editing and cell engineering strategies.

Learn more

Jun. Prof. Dr. Matthias Gehringer

Junior Professorship for Medicinal Chemistry

Jun. Prof. Dr. Matthias Gehringer took up his W1 professorship for Medicinal Chemistry at the Faculty of Medicine in 2019. Jun. Prof. Gehringer's research interests include medicinal chemistry, chemical biology, the total synthesis of natural products and targeted drug approaches. Current research focuses on the design of covalent protein kinase inhibitors and the development of novel electrophilic warheads for covalent targeted approaches. Special efforts are devoted to the development of highly selective chemical probes for mapping the non-targeted kinome.

Learn more

© Universitätsklinikum Tübingen

Prof. Dr. Mathias Heikenwälder

© Universitätsklinikum Tübingen / Beate Armbruster
Professorship for Chronic Inflammation and Cancer Research

Prof. Dr. Mathias Heikenwälder has taken up his W3 professorship for Chronic Inflammation and Cancer Research at the Faculty of Medicine on October 1, 2023. Mathias Heikenwälder's research interests are aimed at understanding the different immune signatures of chronic inflammatory human diseases that trigger cancer - with the ultimate goal of developing suitable mouse models for preclinical research and translation into the clinic. One focus is therefore to understand how inflammation (triggered by lifestyle factors or pathogens (e.g. viruses or bacteria) triggers cancer in regenerative organs (such as the liver or gastrointestinal tract).

Learn more

Prof. Dr. Anna Junker

Professorship for Radiochemistry and imaging probe development

Prof. Dr. Anna Junker has taken up her W2 professorship for Radiochemistry and Imaging Probe Development at the Faculty of Medicine on January 1, 2024. Prof. Junker's scientific focus is on the development of novel ligands and inhibitors for various oncologically relevant G-protein coupled receptors, ion channels and enzymes as well as the further development of these ligands and inhibitors into imaging probes.

Learn more

© Universitätsmedizin Münster

Jun. Prof. Dr. Josef Leibold

© Universitätsklinikum Tübingen / Beate Armbruster
Junior Professorship for Functional Immunogenomics

Prof. Dr. Josef Leibold took up his W1 professorship for Functional Immunogenomics at the Faculty of Medicine on September 15, 2020. Prof. Leibold's research focuses on the interaction between tumor genetics and the mechanisms of tumor immune surveillance and tumor immune escape. He pursues translational approaches with the aim of developing new therapy options.

Learn more

Prof. Dr. André Martins

Professorship for Advanced Preclinical Metabolic Imaging and cell Engineering

Prof. Dr. André Martins took up his W3 professorship for Advanced Preclinical Metabolic Imaging and cell Engineering at the Faculty of Medicine on January 24, 2022. The W3 professorship, which is partially funded by the Alexander von Humboldt Foundation, focuses on the development of non-invasive metabolic sensors and technologies for clinical diagnostics and therapy. The goal of Martins and his team is to functionally enable non-invasive monitoring, prediction, selection and image-guided tumor metabolic therapies. The research will support image-guided response to immune checkpoint inhibitor therapies, cellular immunotherapies (e.g. CAR T-cells or adoptive T-cell transfer) and combinatorial therapies.

Learn more

© Universitätsklinikum Tübingen

Prof. Dr. Christian Schürch

Professorship for Advanced Tissue Imaging and Digital Pathology

Prof. Dr. Christian Schürch has taken up his W3 professorship for Advanced Tissue Imaging and Digital Pathology at the Faculty of Medicine in 2021. Prof. Schürch and his team focus on understanding tumor immunology and the tumor microenvironment in human cancer and mouse tumor models by using high-multiplex microscopy and machine learning-based computational analysis.

Learn more

© Universitätsklinikum Tübingen / Thanh Thanh Nguyen

Prof. Dr. Lisa Sevenich

© Frankfurt Cancer Institute / Uwe Dettmar
Professorship for Experimental Neuroonco-Immunology 

Prof. Dr. Lisa Sevenich has taken up her W2 professorship for Experimental Neuroonco-Immunology at the Faculty of Medicine on December 15, 2023. Her scientific focus is on the mechanistic investigation of interactions between tumor cells and the brain's own and systemic immune cells in brain metastasis. Sevenich places a particular focus on the elucidation of resistance mechanisms to standard and immunotherapy in cerebral tumors. To this end, she uses a broad spectrum of preclinical models and patient samples to understand complex cellular interactions that prevent an anti-tumor immune response by means of high-resolution imaging and multi-omics analyses.

Learn more

Prof. Dr. Juliane Walz

Professorship for Peptid-based Immunotherapy

Prof. Dr. Juliane Walz took up her W3 professorship for peptide-based immunotherapy at the Faculty of Medicine on April 1, 2022. The overarching goal of Ms Walz's research activities in the field of immunology is the development of new peptide-based immunotherapy concepts for tumor and infectious diseases. The identification, characterization and modification of such tumor- or infection-associated peptides by means of mass spectrometric immunopeptidome analysis is a focus of Ms. Walz's work.

Learn more

© Universitätsklinikum Tübingen / Beate Armbruster

Prof. Dr. Bettina Weigelin

© Universitätsklinikum Tübingen / Beate Armbruster
Professorship for Preclinical Imaging of the Immune System

Prof. Dr. Bettina Weigelin has taken up her W2 professorship for Preclinical Imaging of the Immune System at the Faculty of Medicine on May 1, 2021. Weigelin's research focuses on the field of intravital microscopy of immune function in solid tumors and their metastases as well as tumor invasion and the general biology of cancer. By visualizing the interaction of individual cells in living tissue, her results contribute to a better understanding of the resistance mechanisms of tumors in order to develop new and more effective approaches for cellular immunotherapy.

Learn more